We report here that the ATP competitive mTOR inhibitor INK128 negatively regulates CD44 translation in HCC possibly by blocking phosphorylation of 4EBP1, a key downstream protein in the mTOR pathway. The gene discussed is CD44; the disease is hepatocellular carcinoma.